Wuxi and Gilead Partner on Dedicated Shanghai Lab for Gilead

WuXi PharmaTech has formed a partnership with Gilead Sciences under which WuXi will equip and operate a dedicated lab in Shanghai for Gilead's small-molecule new chemical entities. The 12,500 square foot cGMP-compliant analytical testing facility will conduct analytical and stability studies. WuXi and Gilead have been working together for some time, the companies said. More details.... Stock Symbols: (NYSE: WX) (NSDQ: GILD) Share this with colleagues: // //